Compile Data Set for Download or QSAR
Report error Found 18 Enz. Inhib. hit(s) with all data for entry = 12709
TargetNuclear receptor ROR-gamma [C285S](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721486(US20250059154, Compound 21)
Affinity DataIC50: 28.1nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C345S](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721485(US20250059154, Compound 14)
Affinity DataIC50: 33.9nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721485(US20250059154, Compound 14)
Affinity DataIC50: 35.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C320S](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721485(US20250059154, Compound 14)
Affinity DataIC50: 36.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C345S](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721486(US20250059154, Compound 21)
Affinity DataIC50: 37.4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C455S](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721485(US20250059154, Compound 14)
Affinity DataIC50: 37.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C285S](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721485(US20250059154, Compound 14)
Affinity DataIC50: 37.6nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C366S](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721485(US20250059154, Compound 14)
Affinity DataIC50: 39nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721486(US20250059154, Compound 21)
Affinity DataIC50: 39.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C278S](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721485(US20250059154, Compound 14)
Affinity DataIC50: 41.3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C320A](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721485(US20250059154, Compound 14)
Affinity DataIC50: 43.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C278S](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721486(US20250059154, Compound 21)
Affinity DataIC50: 46.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C393S](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721486(US20250059154, Compound 21)
Affinity DataIC50: 48.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C366S](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721486(US20250059154, Compound 21)
Affinity DataIC50: 50.3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C455S](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721486(US20250059154, Compound 21)
Affinity DataIC50: 52.6nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C320S](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721486(US20250059154, Compound 21)
Affinity DataIC50: 58.3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C393S](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721485(US20250059154, Compound 14)
Affinity DataIC50: 60.4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma [C320A](Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM721486(US20250059154, Compound 21)
Affinity DataIC50: 64.1nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/19/2025
Entry Details
Go to US Patent